SNSE (Sensei Biotherapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SNSE stock?
Hedge funds tracked by Rallies that own SNSE include Duquesne Family. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sensei Biotherapeutics, Inc. Common Stock.
SNSE Key Metrics
Key financial metrics for SNSE
Metric
Value
Price
$17.58
Market Cap
$26.70M
P/E Ratio
-1.04
EPS
$-16.72
Dividend Yield
0.00%
52-Week High
$36.76
52-Week Low
$5.00
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-21.09M
Gross Margin
0.00%
Top Hedge Funds Holding SNSE
Duquesne Family holds 100.00K shares of SNSE, changed +0.00% as of Dec 31, 2023.
MILLENNIUM MANAGEMENT LLC bought 1.11K (~$36.99K) on Apr 7, 2026.
MILLENNIUM MANAGEMENT LLC sold 2.12K (~$61.21K) on Apr 7, 2026.
MILLENNIUM MANAGEMENT LLC sold 205 (~$6.09K) on Apr 7, 2026.
SNSE Analyst Consensus
SNSE analyst coverage data. Average price target: $0.00.
Common questions about SNSE
Who owns SNSE stock?
Hedge funds tracked by Rallies that own SNSE include Duquesne Family. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sensei Biotherapeutics, Inc. Common Stock.
Does Rallies show 13F holders for SNSE?
Yes. Rallies tracks hedge fund and 13F ownership data for SNSE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SNSE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNSE. It does not provide personalized investment advice.